OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 1
Data from combined, up to 2021-03-17.
| Vaccinated at 2021-03-17 (%) | Vaccinated at 2021-03-17 (n) | Population | Vaccinated at 2021-03-10 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 66.3% | 200,249 | 301,882 | 65.6% | 0.7% |
| Sex | Female | 66.7% | 127,813 | 191,709 | 66.2% | 0.5% |
| Male | 65.7% | 72,436 | 110,173 | 64.7% | 1.0% | |
| Ethnicity | White - British | 66.9% | 128,387 | 191,968 | 66.2% | 0.7% |
| White - Irish | 67.9% | 1,701 | 2,506 | 67.6% | 0.3% | |
| White - Any other White background | 58.0% | 3,647 | 6,293 | 57.0% | 1.0% | |
| Mixed - White and Black Caribbean | 59.3% | 357 | 602 | 57.0% | 2.3% | |
| Mixed - White and Black African | 50.0% | 126 | 252 | 47.2% | 2.8% | |
| Mixed - White and Asian | 60.6% | 140 | 231 | 60.6% | 0.0% | |
| Mixed - Any other mixed background | 62.3% | 301 | 483 | 59.4% | 2.9% | |
| Asian or Asian British - Indian | 64.1% | 1,323 | 2,065 | 62.7% | 1.4% | |
| Asian or Asian British - Pakistani | 55.6% | 490 | 882 | 53.2% | 2.4% | |
| Asian or Asian British - Bangladeshi | 60.3% | 245 | 406 | 56.9% | 3.4% | |
| Asian or Asian British - Any other Asian background | 57.6% | 686 | 1,190 | 56.5% | 1.2% | |
| Black or Black British - Caribbean | 58.1% | 1,330 | 2,289 | 56.9% | 1.2% | |
| Black or Black British - African | 50.2% | 707 | 1,407 | 48.8% | 1.5% | |
| Black or Black British - Any other Black background | 57.4% | 434 | 756 | 54.6% | 2.8% | |
| Other ethnic groups - Chinese | 56.9% | 203 | 357 | 56.9% | 0.0% | |
| Other ethnic groups - Any other ethnic group | 59.6% | 693 | 1,162 | 58.4% | 1.2% | |
| Patients with any other ethnicity code | 67.9% | 26,481 | 38,983 | 67.2% | 0.7% | |
| Ethnicity not stated | 64.7% | 1,785 | 2,758 | 64.2% | 0.5% | |
| Ethnicity not recorded | 66.0% | 31,108 | 47,166 | 65.4% | 0.5% | |
| Ethnicity (broad categories) | White | 66.6% | 133,749 | 200,788 | 65.9% | 0.7% |
| Mixed | 58.8% | 938 | 1,596 | 56.6% | 2.2% | |
| South Asian | 60.6% | 2,765 | 4,564 | 58.9% | 1.7% | |
| Black | 55.7% | 2,485 | 4,459 | 54.2% | 1.6% | |
| Other | 58.4% | 896 | 1,533 | 57.5% | 0.9% | |
| Unknown | 66.8% | 59,388 | 88,914 | 66.2% | 0.6% | |
| Index of Multiple Deprivation | 1 (most deprived) | 64.2% | 39,060 | 60,872 | 63.3% | 0.8% |
| 2 | 68.5% | 43,148 | 63,035 | 67.5% | 0.9% | |
| 3 | 67.8% | 43,050 | 63,525 | 67.1% | 0.6% | |
| 4 | 66.5% | 40,243 | 60,522 | 65.9% | 0.6% | |
| 5 (least deprived) | 64.6% | 33,607 | 52,059 | 64.1% | 0.4% | |
| Unknown | 60.8% | 1,120 | 1,841 | 58.9% | 1.9% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 67.4% | 175,483 | 260,421 | 66.7% | 0.7% |
| Patients with Immunosuppression | 65.4% | 6,020 | 9,205 | 64.8% | 0.6% | |
| Patients with CKD | 66.3% | 49,903 | 75,250 | 66.0% | 0.3% | |
| Patients who have Chronic Respiratory Disease | 65.8% | 18,368 | 27,902 | 65.4% | 0.5% | |
| Patients with Diabetes | 66.6% | 38,017 | 57,050 | 66.1% | 0.6% | |
| Patients with Chronic Liver disease | 65.4% | 5,173 | 7,910 | 64.2% | 1.2% | |
| Patients with CNS Disease (including Stroke/TIA) | 68.5% | 104,874 | 153,076 | 67.9% | 0.6% | |
| Patients with Chronic heart disease | 66.5% | 72,296 | 108,647 | 66.2% | 0.4% | |
| Patients with Asplenia or Dysfunction of the Spleen | 67.0% | 1,547 | 2,310 | 66.1% | 0.9% | |
| Patients with Wider Learning Disability | 74.7% | 33,845 | 45,297 | 72.9% | 1.8% | |
| Patients with Severe Mental Health | 66.0% | 19,880 | 30,142 | 64.7% | 1.2% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 67.7% | 143,339 | 211,806 | 67.3% | 0.4% |
| Patients with Morbid Obesity | 66.7% | 5,453 | 8,176 | 65.1% | 1.6% | |
| Patients who are pregnant | 23.8% | 35 | 147 | 23.8% | 0.0% |